Is Ribociclib domestically produced or imported?

The original drug Ribociclib ( Ribociclib) is an imported drug and is currently on the market in China. However, due to its short time on the market, it has not yet been included in the scope of medical insurance. There is currently no domestically produced drug for Riboxil available on the market. Reboxiclib is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with other agents: an aromatase inhibitor as initial endocrine-based therapy; or with Fulvestrant as initial endocrine therapy in postmenopausal women or men or after disease progression.